![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_025fe4aaa487a6771e8d4765d8aa24d6.svg) | (R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol | IC50 | 0.66 [1], 0.74 [2], 0.82 [3], 1.4 [4], 520.0 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_025fe4aaa487a6771e8d4765d8aa24d6.svg) | (R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol | Ki | 0.15 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_7ce5c90b273b41810bee3170ac9401d3.svg) | Haloperidol | Ki | 107.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_0ef8e49ad0f17d5eb8cd799eb0c079f1.svg) | 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine | Ki | 60.4 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_f5710ce8638ea66133e6da4c26e3503a.svg) | Sch-23390 maleate | IC50 | 0.22 [1], 0.27 [2], 1.7 [3], 30.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_f5710ce8638ea66133e6da4c26e3503a.svg) | Sch-23390 maleate | Ki | 0.1 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_423b81e49046b6b59498c10bdf1ee695.svg) | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-6-ol | Ki | 1.35 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_35d56fcbf04ce0cae8d36a54a803b51a.svg) | (13As)-3,9,11-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | IC50 | 9.85 [1], 1380.0 [2], 1400.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_35d56fcbf04ce0cae8d36a54a803b51a.svg) | (13As)-3,9,11-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | Ki | 2.5 [1], 2.53 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_c871e436119b1d6f92ea7571ed4647e5.svg) | Quetiapine | Ki | 214.6 [1], 390.0 [2], 1000.0 [3], 1300.0 [4], 4240.0 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_d811ff998f113bbc25cc86ab4baf596e.svg) | 7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol | IC50 | 0.31 [1], 2.52 [2], 740.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_d811ff998f113bbc25cc86ab4baf596e.svg) | 7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol | Ki | 1.2 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_513d055dce192a3154542363c30bcd77.svg) | l-Stepholidine | Ki | 3.4 [1], 5.9 [2], 6.23 [3], 12.29 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_69cdad9a7cffce891b22d99e3d466366.svg) | (+)-Dihydrexidine | Ki | 6.2 [1], 33.0 [2], 35.7 [3], 1200.0 [4] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_b2af828982a0ff14c22035ae80fc67dc.svg) | 1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, (1R)- | Ki | 5.1 [1], 56.0 [2], 73.0 [3], 130.0 [4], 320.0 [5] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_a11e917941292cd335a17a10ba1ed6a7.svg) | 6-Methoxy-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaene | Ki | 22.91 [1], 24.1 [2], 28.5 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_2b2555cb7db13250c1504643b792e537.svg) | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3,5,7,14,16-hexaene | Ki | 3.47 [1], 4.5 [2], 40.4 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_e73173f946f838886a8a4b331b7f2e1d.svg) | Ecopipam | Ki | 1.2 [1], 1.9 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_1c4c66d61ead168cc4a45d88dbd08070.svg) | (13As)-3-methoxy-9,11-dimethyl-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | IC50 | 56.37 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_1c4c66d61ead168cc4a45d88dbd08070.svg) | (13As)-3-methoxy-9,11-dimethyl-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | Ki | 28.9 [1], 28.91 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_1702ec4e91a6e6ac7ec0735114adb8a6.svg) | Ziprasidone | Ki | 9.5 [1], 130.0 [2], 330.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_33db7f8318151425ce0abc5f717da19c.svg) | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | Ki | 190.0 [1], 393.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_0fb673892a382c008d28c337d8e4f028.svg) | N-Propylnorapomorphine | Ki | 1.0 [1], 490.0 [2], 1510.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_4cb4c62db392b745786fd6e06814e5ac.svg) | (6Ar)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol | Ki | 45.0 [1], 4300.0 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_98c4b1b19cda609bc80701b18072fbcc.svg) | 7-Chloro-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-6-ol | Ki | 0.46 [1], 0.81 [2], 0.83 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_0cc6dba9b3da1c343f6d3b867a9a54ca.svg) | 12-Methyl-12,22-diazatetracyclo[13.7.0.03,8.016,21]docosa-1(15),3,5,7,16,18,20-heptaene | Ki | 2.04 [1], 2.2 [2], 2.8 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_70756e939f1ad1f57fbb16a0fa012ca0.svg) | 11-Methyl-11,22-diazatetracyclo[13.7.0.03,8.016,21]docosa-1(15),3,5,7,16,18,20-heptaene | Ki | 158.49 [1], 163.5 [2], 304.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_682160e093b8b171992a0f4bbe628bc9.svg) | 10-Methyl-6-thia-10-azatricyclo[11.4.0.03,7]heptadeca-1(17),3(7),4,13,15-pentaene | Ki | 4.0 [1], 10.7 [2], 207.0 [3] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_13c232aed22a7207367eebd98d23c86c.svg) | (1S)-16,18-Dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene | IC50 | 141.58 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_13c232aed22a7207367eebd98d23c86c.svg) | (1S)-16,18-Dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene | Ki | 64.12 [1], 74.51 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_86b63047f258c22b32104325d46e98d5.svg) | (13As)-3,9,12-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | IC50 | 7.22 [1], 1900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_86b63047f258c22b32104325d46e98d5.svg) | (13As)-3,9,12-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | Ki | 3.7 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_a7e11d7bcee94c9af8c42c557a082c25.svg) | Chlorpromazine | Ki | 96.0 [1], 112.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_946b0b501eb57b26c13e79111c2b1587.svg) | Amitriptyline | Ki | 89.0 [1], 178.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_53e0258413dfe8503285a6d017480c2b.svg) | Fluphenazine | Ki | 11.0 [1], 179.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_415eea9f8f6bffcaeb1207bd9602c9d9.svg) | Pergolide | Ki | 339.0 [1], 2020.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_f85b981aff74836d1966893658eae4a2.svg) | Maprotiline | Ki | 187.0 [1], 402.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_3b7395ec254589f5d3f9a4cc5434da86.svg) | Lisuride | Ki | 77.0 [1], 86.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_0a5cc2f3d9f058fddf9325dd37c23ad6.svg) | Tetrahydropalmatine | Ki | 153.0 [1], 231.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_6cb3ea27fe013e7dda2c01a588aff4ff.svg) | Zotepine | Ki | 29.0 [1], 84.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ff8d4194409d8fceaa071169fcd4b4d4.svg) | GR-127935 | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_8873e7c98d1d6dd57f09c4a8cd059afc.svg) | Cariprazine | Ki | 2100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_d9f5b37619ce09956b13a54b7e2887b7.svg) | 3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine | Ki | 1.18 [1], 1.93 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_6cf5ecbb9a1c42bdc42ce186d840229c.svg) | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | Ki | 760.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_613bd559e314252ec76ed0cdf79b77e9.svg) | 5-(4-Chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | IC50 | 2000.0 [1], 7000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_b7ec8ee22e163a789aab218107293e10.svg) | (S)-Canadine | Ki | 48.6 [1], 66.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_df20649e63f6814da658fbc9fd2ea41a.svg) | 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_df20649e63f6814da658fbc9fd2ea41a.svg) | 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_135e1b51c4285a8ab5ce02f8e0f91fbe.svg) | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | Ki | 1195.0 [1], 8800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_1a2aea6d929cec92601f9fc0ce2cb1eb.svg) | Di-deacetyl adrogolide | Ki | 49.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_b311055e2bfa89a39ca02a6a3c09ba08.svg) | Corydalmine | Ki | 50.0 [1], 107.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_da9a9cc8e5c7237e38b5596d82a38c22.svg) | N-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]pyrazolo[1,5-a]pyridine-2-carboxamide | Ki | 1500.0 [1], 1600.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_421b8d1934e3715ea1028700fe65fa1f.svg) | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | Ki | 670.0 [1], 800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ff64e43e21792a01dbcabf7d3275a6b9.svg) | (S)-Tetrahydrocolumbamine | Ki | 4.5 [1], 6.2 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_be087b7f2ed166a1dd467c6e8de97e8c.svg) | 2-Methoxy-N-n-propylnorapomorphine | Ki | 8.1 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_760c170bad01a1c163e866a9dbce9f05.svg) | N-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 1100.0 [1], 2000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_5ba5609e9769ac2ad093c3ba45619f4d.svg) | Corypalmine | Ki | 199.0 [1], 310.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_bcbb36a6cad84298c3dc74af8f90788c.svg) | N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)benzofuran-2-carboxamide | Ki | 2100.0 [1], 2900.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_850395749223cdae413860bd86bdc57d.svg) | 7-[4-[4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one | Ki | 340.0 [1], 825.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_b905c9857f9d162d269fece8c415e017.svg) | (6S)-6-[2-Phenylethyl(propyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol | Ki | 230.0 [1], 1200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_4f44aba651a0b3cb30f937f6b1ceb99c.svg) | 5-[2-[4-(2,3-Dimethylphenyl)piperazin-1-yl]ethyl]-2H-benzotriazole | Ki | 4677.35 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_fcecca4301ff62eb7aefc0921887a64b.svg) | (1R,11S)-5-Chloro-10-methyl-10-azatetracyclo[9.7.0.02,7.013,18]octadeca-2,4,6,13,15,17-hexaen-4-ol | Ki | 7.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_142fbbeb54ce3bc1ea66980acab78f6a.svg) | 2-Chloro-N-[3-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]benzamide | Ki | 4.0 [1], 4.1 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_9e46422bb4b68027d17519474cd74133.svg) | 11-Methyl-11-azatricyclo[13.4.0.03,8]nonadeca-1(19),3(8),4,6,15,17-hexaen-6-ol | Ki | 2.67 [1], 3.2 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_2ad048537eb55f41d5436998aa5fd4a2.svg) | 17-Methoxy-11-methyl-11-azatricyclo[13.4.0.03,8]nonadeca-1(15),3,5,7,16,18-hexaene | Ki | 28.18 [1], 29.4 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_fc1f9df7d3be8ef1aa8f6a60bb675f3f.svg) | 6-Methoxy-11-methyl-11-azatricyclo[13.4.0.03,8]nonadeca-1(19),3(8),4,6,15,17-hexaene | Ki | 18.5 [1], 21.88 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_94f8069bec00d70dc34055f46c3e13e8.svg) | 5'-Chloro-N,N-dimethylspiro[cyclohex-2-ene-4,2'-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,9,11,13-heptaene]-1-amine | Ki | 0.3 [1], 3.1 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_01e893dd2ae76d41f0a657220a6b7747.svg) | (1S)-16-Methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaen-17-ol | Ki | 6.3 [1], 6.5 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_83c11ba288921e52e6e6c9fd774e784f.svg) | 10-[2-[(2R)-1-Methylpiperidin-2-yl]ethyl]-2-methylsulfinylphenothiazine | IC50 | 137.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_83c11ba288921e52e6e6c9fd774e784f.svg) | 10-[2-[(2R)-1-Methylpiperidin-2-yl]ethyl]-2-methylsulfinylphenothiazine | Ki | 103.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ebde3674c665e9289c5a5c2559a9c384.svg) | N-[3-Chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]-4-methoxybenzamide | Ki | 47.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_fa6efe97418e72fb9fc93f321986e3b0.svg) | N-[3-Chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]benzamide | Ki | 157.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_f4389e9852cbdf2efa1e0e1b99e553f5.svg) | N-[3-Chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]-2,6-dimethoxybenzamide | Ki | 1.6 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_d8bd038f582f4c297155d0dba0bf0124.svg) | N-[3-Chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]-2,6-dimethylbenzamide | Ki | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_e3a891adf4c133d1786f7a7b31238020.svg) | 11-Methyl-11,21-diazatetracyclo[12.7.0.03,8.015,20]henicosa-1(14),3,5,7,15(20),16,18-heptaen-17-ol | Ki | 0.56 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_8a68fbc2de6edc73a5c4c862071375ae.svg) | (4As,5R,10bR)-5-phenyl-1,2,3,4,4a,5,6,10b-octahydrobenzo[h]isoquinoline-7,8-diol | Ki | 47.0 [1], 18000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ab6483730203591a6bef47a00853b878.svg) | 2-[[(2R)-2-Phenethylmorpholino]methyl]-1H-benzoimidazole | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ab6483730203591a6bef47a00853b878.svg) | 2-[[(2R)-2-Phenethylmorpholino]methyl]-1H-benzoimidazole | Ki | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ba7e56c42f244b807f37bb5aa13360fa.svg) | (13As)-3,11-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | Ki | 35.79 [1], 35.8 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_ad9c8006fa3b60e966c528788b5e3186.svg) | (13As)-12-(hydroxymethyl)-3,9,11-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | Ki | 17.29 [1], 17.3 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_504a1b351ff740b1146d2ae1af434d7a.svg) | 6,10-Dimethyl-6,10-diazatricyclo[11.4.0.03,7]heptadeca-1(17),3(7),4,13,15-pentaene | Ki | 61.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_c302d6aec916ac720fe61fe592b0c00c.svg) | 4-[2-(1H-Benzotriazol-5-yl)ethyl]-1-(2-methoxyphenyl)piperazine | Ki | 812.83 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_45d6a51fb8802aaf83e6e0dbde43bb41.svg) | 4-[2-(1H-Benzotriazol-5-yl)ethyl]-1-(1-naphthyl)piperazine | Ki | 5754.4 [1] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_fa184dd9c2b496bd7fb5416acbe22721.svg) | 5,7-Dichloro-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3,5,7,14,16-hexaen-6-ol | Ki | 3.2 [1], 3.8 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_b878572db5e6d751add56c85633979c4.svg) | 5-Methoxy-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaene | Ki | 82.0 [1], 567.0 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_3ec9b1478244abcbee301d969963d88e.svg) | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-4-ol | Ki | 8.7 [1], 64.1 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_9faccd9f6716f65fc09df26313820058.svg) | 4-Methoxy-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaene | Ki | 7.6 [1], 37.6 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_e099cf7b69fe95fabc5e32c3fbc147a6.svg) | 5-Amino-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3,5,7,14,16-hexaen-6-ol | Ki | 9.3 [1], 20.9 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_26244f6b8a078197b89df7e5a25fd4f7.svg) | 6-Chloro-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3,5,7,14,16-hexaen-5-ol | Ki | 3.1 [1], 10.8 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_8e82315011e0e7185dd99c21adc5fadf.svg) | 6,16-Dimethoxy-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(14),3(8),4,6,15,17-hexaene | Ki | 9.4 [1], 26.9 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_c20681ea0d74db9d230732c2b7b0a7d5.svg) | 4-Chloro-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-5-ol | Ki | 0.46 [1], 6.8 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_10d5e4fc375f583019507450b4634e8d.svg) | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(14),3(8),4,6,15,17-hexaene-6,16-diol | Ki | 2.0 [1], 3.3 [2] |
![](https://images.aatbio.com/dataset/ic50/dopamine-d1-receptor_77f79863d0a7b720e50d216ed8536ddf.svg) | 11-Methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaen-5-ol | Ki | 2.6 [1], 8.9 [2] |